Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into.

Slides:



Advertisements
Similar presentations
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Advertisements

Homocysteine and metabolic syndrome: From clustering to additional utility in prediction of coronary heart disease Alireza Esteghamati, MD, Nima Hafezi-Nejad,
HOW THE HEART WORKS BLOOD FLOW THROUGH THE HEART.
Volume 32, Issue 9, Pages (September 2016)
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study  Dr Jack R W Brownrigg,
Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population  Sharmini Selvarajah, Gurpreet.
Lifestyle Interventions in Patients with Coronary Heart Disease
Volume 56, Issue 1, Pages (July 1969)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin  S. Goya Wannamethee, A. Gerald Shaper, Peter.
Copyright © 2007 American Medical Association. All rights reserved.
ELIGIBILITY: MRC/BHF Heart Protection Study
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Remko Kockelkoren, Pushpa M Jairam, John T. Murchison, Thomas P. A
M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal  Gregory.
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis  Sarah A. Anderson, John.
The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study  Ido Weinberg, Philimon Gona, Christopher.
Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies  Xia Wang, Yingying.
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY.
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Systematic Review of Guidelines on Peripheral Artery Disease Screening
Systematic review of guidelines on abdominal aortic aneurysm screening
Erik O. Udo, Norbert M. van Hemel, Nicolaas P. A
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort  Dexter Canoy, Benjamin J. Cairns, Angela.
Alan Gradman  Journal of Indian College of Cardiology 
Journal of Indian College of Cardiology
B.M. Biccard, R.N. Rodseth  British Journal of Anaesthesia 
M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M
What does STOP-2 tell us about management of hypertension?
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Primary and Secondary Prevention of Cardiovascular Disease
Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs  Tessa S.S. Genders, Bart.
Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study  C.A. Rushton, U.T. Kadam  International.
Description of studies for pooled analyses
Cardiovascular disease in women with HIV-1 infection
Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease  Anna Maria Izquierdo-Porrera,
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Volume 352, Pages S15-S18 (October 1998)
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome  Jonas Faxén, Hong Xu,
Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death 
International Journal of Cardiology
Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population  Sharmini Selvarajah, Gurpreet.
Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012  A.C.E.
Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5million.
Support Your Specialty
Bouwe P. Krijthe, Maarten J. G. Leening, Jan Heeringa, Jan A
Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations  Willem J. Verberk, Stefano.
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Volume 17, Issue 2, Pages (February 1950)
Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: A randomized controlled trial.
Maxim Grymonprez, Vincent Vakaet, Maryam Kavousi, Bruno H. Stricker, M
International Journal of Cardiology
Nicholas T Kouchoukos, MD  The Annals of Thoracic Surgery 
International Journal of Cardiology
Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension  Johannes M. Douwes, Marcus T.R. Roofthooft,
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Daniel Bos, Meike W. Vernooij, Renée F. A. G. de Bruijn, Peter J
Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation  Finlay A. McAlister,
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
International Journal of Cardiology
International Journal of Cardiology
Presentation transcript:

Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke  Bob J.H. van Kempen, Bart S. Ferket, Maryam Kavousi, Maarten J.G. Leening, Ewout W. Steyerberg, M. Arfan Ikram, Jacqueline C.M. Witteman, Albert Hofman, Oscar H. Franco, M.G. Myriam Hunink  International Journal of Cardiology  Volume 171, Issue 3, Pages 413-418 (February 2014) DOI: 10.1016/j.ijcard.2013.12.036 Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 1 Calibration plot, showing predicted and observed 15-year risk of CVD for each decile of predicted 15-year CVD risk, based on the original Framingham CVD function [3] (model 1, left) and the recalibrated score by adjusting baseline hazards of CVD and non-CVD death (model 2, right). International Journal of Cardiology 2014 171, 413-418DOI: (10.1016/j.ijcard.2013.12.036) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 2 Calibration plot, showing predicted and observed 15-year risk of CVD for each decile of predicted 15-year CVD risk, based on the refitted function (model 4, left) and refitting the CVD and non-CVD death function, by separately analyzing CHD and stroke (model 5, right). International Journal of Cardiology 2014 171, 413-418DOI: (10.1016/j.ijcard.2013.12.036) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 3 Calibration plot, showing predicted and observed 15-year risk of competing non-CVD death for each decile of predicted 15-year CVD risk, based on the original Framingham CVD function [3] (model 1, left) and after refitting the CVD and non-CVD death function in the Rotterdam Study data (model 4, right). International Journal of Cardiology 2014 171, 413-418DOI: (10.1016/j.ijcard.2013.12.036) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 4 Individual predictions for 4 individuals: (a) 70-year old woman, smoker, systolic blood pressure of 103, total (HDL) cholesterol 4.1mmol/L 1.5, treated for hypertension; (b) 70-year old man, systolic blood pressure of 132, total (HDL) cholesterol 5.0mmol/L 1.80, diabetic; (c) 56-year old man, systolic blood pressure of 124, total (HDL) cholesterol 6.4mmol/L 0.9; and (d) 65-year old woman, systolic blood pressure of 129, total (HDL) cholesterol 6.7mmol/L 0.9, treated for hypertension. International Journal of Cardiology 2014 171, 413-418DOI: (10.1016/j.ijcard.2013.12.036) Copyright © 2014 Elsevier B.V. Terms and Conditions